Quick Links

This month in Pharmacy Times

May 2018 Skin & Eye Health

Criminal Liability of a Salesclerk Under the Federal Food, Drug, and Cosmetic Act

Demonstrated Glycemic Control in Adults With Diabetes Mellitus With Fiasp (insulin aspart injection) 100 U/mL

Anticoagulation In The Management of CAD and PAD

Pharmacists Break Out on Their Own

Triptans and SSRIs

Getting Ready for Vacation: How Brown Bagging Can Bring Clarity

Pet Peeves (May 2018)

The Benefits of Abuse-Deterrent Opioids

SEPTEMBER 11, 2017

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the benefits of abuse-deterrent opioids.

SHARE THIS

◄

0

#APharmacistIs Tweets

RELATED COVERAGE

Despite Increased Access, Naloxone Prescription Rates Low in Study

Despite Increased Access, Naloxone Prescription Rates Low in Study

Should Controlled Substances Be Placed in Unit Dose Packaging for Child Safety?

Should Controlled Substances Be Placed in Unit Dose Packaging for Child Safety?

Emergency Department Changes

Emergency Department Changes

YOU MAY ALSO BE INTERESTED IN

FDA Approves First Continuous Glucose Monitoring System with Fully Implantable Sensor

FDA Approves First Continuous Glucose Monitoring System with Fully Implantable Sensor

Automated Insulin Delivery and Monitoring System Approved by FDA for Use in Younger Pediatric Patients

Automated Insulin Delivery and Monitoring System Approved by FDA for Use in Younger Pediatric Patients

Pharmacist and Physician Collaboration Gives Physicians More Freedom

Pharmacist and Physician Collaboration Gives Physicians More Freedom

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER

Personalize the information you receive by selecting targeted content and special offers.